Major Review Of EU Pharmaceutical Legislation Kicks Off
Roadmap Published As Part Of EU Pharma Strategy
Executive Summary
The European Commission has launched the process for reshaping and addressing the long-standing weakness in the EU’s pharmaceutical legislation. It has listed in a roadmap the issues it wants to address as it considers policy options for reforms.